Search results
4 lut 2015 · How do antibody titers evolve following treatment? Ehrlichia canis. Antibody titers may persist for months. Then, in most E. canis infections, they decrease gradually over 6-9 months post treatment. Sometimes, antibodies are no longer detectable at 12 months.
- Sections
Parasites & Vectors focusses on all aspects of the biology...
- About
We welcome outstanding research on the biology of parasites,...
- Submission Guidelines
This is a picture which will appear underneath the Abstract...
- Sections
This manuscript reviews the current state of knowledge regarding treatment of ehrlichiosis, caused by E. canis infection in dogs, provides expert opinion guidelines for the management of the CME-associated aplastic pancytopenia, and outlines methods for evaluation of treatment outcomes.
canis infection far outweigh those for the other canine ehrlichial infections, this article will brie fl y review the pathogenesis, and will emphasize on the diagnosis and treatment of E. canis- induced CME .
26 sty 2017 · Ehrlichia sp. can cause canine monocytic ehrlichiosis (CME), which is a fatal disease in dogs that requires rapid and accurate diagnosis to initiate appropriate therapy and is a very...
4 lut 2015 · Prevalence rates are high for Ehrlichia and Anaplasma spp. infections in dogs from different European countries. The goal of this article was to provide a practical guideline for veterinary practitioners on the diagnosis, treatment, and prevention of ehrlichiosis and anaplasmosis in dogs from Europe.
23 wrz 2017 · This article outlines briefly the pathogenesis of CME due to E. canis, and more thoroughly reviews the recent scientific literature pertaining to the diagnosis and treatment of this devastating disease. Canine monocytic ehrlichiosis (CME) is a tick-borne disease of worldwide distribution.
This manuscript reviews the current state of knowledge regarding treatment of ehrlichiosis, caused by E. canis infection in dogs, provides expert opinion guidelines for the management of the CME-associated aplastic pancytopenia, and outlines methods for evaluation of treatment outcomes. 2019 Elsevier Ltd.
